| Article

A pre-planned analysis of the CARD trial (NCT02485691) demonstrated better patient-reported outcomes (PROs) with cabazitaxel (Jevtana) compared with either abiraterone (Zytiga) or enzalutamide (Xtandi) in men with metastatic castration-resistant prostate cancer (mCRPC) who were previously treated...

| Video

Clinical pharmacist Mark Garofoli offers a strategic thought process for appropriate selection of medications for patients with muscle spasm and/or muscle spasticity.

| Article

Newswise — A visit to the doctor’s office typically begins with a series of questions, including one about medications. An Iowa State University researcher recommends doctors ask a follow up to that question to make sure patients are taking their medications as prescribed.

Alison Phillips, an...

Subscribe to medication management

Sign Up

Subscribe to the PAINWeek Newsletter
and get our latest articles and more directly in your inbox.